niaid-led study of mrna vaccine supports advance to phase 3 animal trials
niaid-led study of mrna vaccine supports advance to phase 3 animal trials
results from early-stage clinical testing indicate the investigational mrna-1273 vaccine is safe and immunogenic, supporting the initiation of a phase 3 clinical trial.